Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Elizabeth K. Duperret
A Novel DNA Vaccine Platform Enhances Neo-Antigen-Like T Cell Responses Against WT1 to Break Tolerance and Induce Anti-Tumor Immunity
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
The Integrin Αv-TGFβ Signaling Axis Is Necessary for Epidermal Proliferation During Cutaneous Wound Healing
Cell Cycle
Medicine
Developmental Biology
Cell Biology
Molecular Biology
Related publications
Potentiating Functional Antigen-Specific CD8+ T Cell Immunity by a Novel PD1 Isoform-Based Fusion DNA Vaccine
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Tumor-Specific Immunity and Antiangiogenesis Generated by a DNA Vaccine Encoding Calreticulin Linked to a Tumor Antigen
Journal of Clinical Investigation
Medicine
GTL001, a Bivalent Therapeutic Vaccine Against Human Papillomavirus 16 and 18, Induces Antigen-Specific CD8+ T Cell Responses Leading to Tumor Regression
PLoS ONE
Multidisciplinary
Optimized DNA Vaccines to Specifically Induce Therapeutic CD8 T Cell Responses Against Autochthonous Breast Tumors
Cancer Immunology, Immunotherapy
Cancer Research
Medicine
Oncology
Allergy
Immunology
Autophagy-Mediated Antigen Processing in CD4+T Cell Tolerance and Immunity
FEBS Letters
Genetics
Cell Biology
Molecular Biology
Biochemistry
Structural Biology
Biophysics
Anti-Tumor Immunity in Adult T-Cell Leukemia
Uirusu. Journal of virology
Medicine
Adjuvant-Enhanced CD4 T Cell Responses Are Critical to Durable Vaccine Immunity
EBioMedicine
Biochemistry
Medicine
Genetics
Molecular Biology
Human HSP70 and Modified HPV16 E7 Fusion DNA Vaccine Induces Enhanced Specific CD8+ T Cell Responses and Anti-Tumor Effects
Oncology Reports
Medicine
Cancer Research
Oncology
Adjuvant Combination and Antigen Targeting as a Strategy to Induce Polyfunctional and High-Avidity T-Cell Responses Against Poorly Immunogenic Tumors
Cancer Research
Cancer Research
Oncology
